Skip to main content
logo
Oryzon Genomics S.A. (FRA:ORN)
Germany flag Germany · Delayed Price · Currency is EUR
3.155
-0.020 (-0.63%)
At close: Jan 30, 2026

Oryzon Genomics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-3.79-3.71-4.52-5.33-4.16
Depreciation & Amortization
0.130.140.160.150.16
Other Amortization
0.020.030.020.010.02
Asset Writedown & Restructuring Costs
---00.01
Other Operating Activities
-1.153.741.03-1.39-0.42
Change in Accounts Receivable
0.010.370.31-0.120.19
Change in Inventory
000.10.24-0.03
Change in Accounts Payable
-0.95-1.250.931.38-1.68
Change in Other Net Operating Assets
-0.160.0300.930.03
Operating Cash Flow
-5.89-0.64-1.97-4.12-5.89
Capital Expenditures
---0.08-0.2-0.19
Sale (Purchase) of Intangibles
-7.98-16.03-15.17-13.18-11.1
Other Investing Activities
-0.11-0-00.040.17
Investing Cash Flow
-8.09-16.03-15.25-13.33-11.11
Short-Term Debt Issued
7.2515.229.57--
Long-Term Debt Issued
6.761.935.479.058.64
Total Debt Issued
14.0117.1515.049.058.64
Short-Term Debt Repaid
--0.9---
Long-Term Debt Repaid
-8.44-7.52-4.73-4.36-8.4
Total Debt Repaid
-8.44-8.42-4.73-4.36-8.4
Net Debt Issued (Repaid)
5.568.7310.34.690.25
Issuance of Common Stock
0.07---21.96
Repurchase of Common Stock
--1.99-1.07--
Other Financing Activities
1.48-0.090.07-0.28
Financing Cash Flow
7.116.669.314.6922.49
Foreign Exchange Rate Adjustments
-0.01-000.40.01
Net Cash Flow
-6.87-10.01-7.92-12.375.5
Free Cash Flow
-5.89-0.64-2.06-4.32-6.08
Free Cash Flow Margin
-77.32%-4.05%-12.25%-35.82%-52.20%
Free Cash Flow Per Share
-0.09-0.01-0.04-0.08-0.12
Cash Interest Paid
0.390.440.340.290.3
Cash Income Tax Paid
--5.16-2.65-1.48-1.05
Levered Free Cash Flow
-14.23-20.58-17.29-17.89-16.51
Unlevered Free Cash Flow
-13.44-19.27-16.54-17.56-16.16
Change in Working Capital
-1.1-0.841.342.43-1.5
Source: S&P Global Market Intelligence. Standard template. Financial Sources.